Williams & Novak’s Viatris VTRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-13,935
Closed -$138K 158
2025
Q3
$138K Sell
13,935
-4,330
-24% -$42.1K 0.11% 118
2025
Q2
$163K Buy
18,265
+4,900
+37% +$41.4K 0.14% 105
2025
Q1
$115K Buy
+13,365
New +$140K 0.11% 102

Other funds holding VTRS

Williams & Novak's VTRS Position: Q4 2025 in Review

Williams & Novak sold out of Viatris (VTRS) in Q4 2025, closing a stake of 13,935 shares — an estimated $138K sold.

Williams & Novak first reported a position in VTRS in Q1 2025 and held it in 3 quarters. The position peaked at $163K in Q2 2025. 1,005 funds tracked by Wall St. Rank hold VTRS as of Q4 2025.

  • Williams & Novak reported no remaining Viatris position as of Q4 2025 after selling out during the quarter.
  • Williams & Novak sold 13,935 Viatris shares in Q4 2025, an estimated $138K.
  • Williams & Novak first reported a position in Viatris in Q1 2025 and held it in 3 quarters.
  • Williams & Novak's Viatris position peaked at $163K in Q2 2025.
  • 1,005 funds tracked by Wall St. Rank held Viatris as of Q4 2025.

Based on Williams & Novak's 13F filing for Q4 2025, filed 5 Feb 2026.